Dr Ben Sholademi, a Senior Clinical Scientist, looks at the work carried out at the Regional Newborn Screening Laboratory.
Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and/or treatment to reduce their risk and/or complications. A screening programme needs to offer more benefit than harm, at a reasonable cost to the NHS. Screening is never 100% sensitive or specific and it is important to appreciate that in any screening programme there is a chance of false-positive and false-negative results.
Click here to read the full article.
Image credit | iStock
